Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q3 FY20 results · Oct–Dec 2019

Advanced Enzyme Technologies reported revenue from operations of ₹111.94 crore (up 10.0% from Q3 FY19) and net profit of ₹34.56 crore (up 36.3% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY20Q3 FY19YoYQ2 FY20QoQ
Revenue from operations111.94101.74+10.0%111.44+0.5%
Other income1.210.00301x1.54−21.5%
Total income113.15101.75+11.2%112.98+0.2%
Profit before tax46.8936.66+27.9%41.60+12.7%
Net profit for the period34.5625.35+36.3%31.84+8.5%
Attributable to shareholders of the company33.6024.45+37.5%30.95+8.6%
EPS, basic (₹)3.012.19+37.4%2.77+8.7%
Net margin (%)30.924.928.6
Standalone · ₹ crore
ItemQ3 FY20Q3 FY19YoYQ2 FY20QoQ
Revenue from operations61.5153.55+14.9%58.91+4.4%
Other income4.970.0954x1.10+350.5%
Total income66.4853.65+23.9%60.01+10.8%
Profit before tax21.808.62+152.8%14.26+52.9%
Net profit for the period17.536.37+175.0%11.15+57.2%
EPS, basic (₹)1.570.57+175.4%1.00+57.0%
Net margin (%)28.511.918.9
Consolidated
Filed with BSE
06 Feb 2020, 17:45 IST
Board meeting
06 Feb 2020
Period
01 Oct 2019 to 31 Dec 2019
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
06 Feb 2020, 17:45 IST
Board meeting
06 Feb 2020
Period
01 Oct 2019 to 31 Dec 2019
Review status
Unaudited
Source
XBRL filing on BSE